"Paradigm Biopharmaceuticals Ltd (ASXAR) has strengthened its board with intellectual property (IP) expertise through the appointment of Amos Meltzer as an independent non-executive director.Meltzer is a scientist and an intellectual property lawyer with more than 25 years of experience in international trade and in commercialising technologies, overwhelmingly in the life sciences.He has presided over life science research and product development projects as well as clinical trials and the sale and marketing of a pharmaceutical product.Amos’ experience and expertise is drawn from having worked in large law firms (Freehills and K&L Gates) and in house counsel and IP director at two Nasdaq-listed companies, as a non-executive director of a biotechnology company and as VP of Business Development and then CEO of an ASX-listed biopharmaceutical company."
whoops
"Paradigm Biopharmaceuticals Ltd (ASX:PAR) has strengthened its...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |